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ABSTRACT 
 
The Severe and Acute Respiratory Syndrome coronavirus (SARS CoV) is a newly-
emerged virus that caused an outbreak of atypical pneumonia in the winter of 2002-2003. 
Polyclonal antibodies raised against the nucleocapsid (N) of the SARS CoV showed the 
localization of N to the cytoplasm and the nucleolus in virus-infected and N-expressing 
Vero E6 cells. Like other coronavirus N proteins, the SARS N is probably a 
phosphoprotein. N protein expressed in mammalian cells is apparently able to “spread” to 
neighboring cells. For N to spread to neighboring cells, it must be exported out of the 
expressing cells. This is shown by the immunoprecipitation of N from the culture 
medium of a stable cell line expressing myc-N. Deletion studies showed that the 27 kD 
C-terminal domain of N (C1/2) is the minimal region of N that can spread to other cells. 
The nucleolar localization and spreading of N are artefacts of fixation, reminiscent of 
other protein-transduction domain (PTD)-containing proteins. 
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INTRODUCTION 
 
In the winter of 2002-2003, a new virus 
that caused SARS, an atypical pneumonia, 
emerged from the Southern part of China 
and infected people from at least 30 
countries. At the end of the outbreak in 
July 2003, the consolidated number of 
patients and deaths due to SARS reported 
by the World Health Organization, was 
8096 and 774 respectively. This outbreak 
not only incurred great social and medical 
costs to affected countries, it also had 
devastating effects on regional as well as 
global economies. 
 
A novel coronavirus was established to be 
the causative agent for SARS (Drosten et 
al., 2003; Ksiazek et al., 2003), and was 
subsequently named SARS coronavirus. Its 
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genome of 29.6 kb revealed 14 open 
reading frames (orfs), encoding the 
replicase, spike, membrane, envelope and 
nucleocapsid (N), which are similar to 
other coronaviruses, and several other 
unique proteins (Marra et al., 2003; Rota et 
al., 2003). 
 
This study describes the characterization of 
N, the nucleocapsid that encapsidates the 
viral RNA during viral particle assembly. 
The N proteins of other coronaviruses have 
been shown to be phosphoproteins 
(Stohlman et al., 1983; Yoo et al., 1992; 
Wootton et al., 2002) that have specific 
RNA-binding activity (Cologna et al., 
2000; Nelson et al., 2000) and RNA 
replication activity (Chang and Brian, 
1996). The SARS CoV N, like two other 
coronaviruses (Hiscox et al., 2001; 
Rowland, 2003), localizes to the nucleolus 
in fixed cells. The SARS CoV N is the 
major antigen recognized by convalescent 
antisera and can be used as a diagnostic 
marker for the detection of SARS 
antibodies (Krokhin et al., 2003; Tan et al., 
2004). Several independent studies showed 
that the N proteins of other coronaviruses 
are relevant targets for T cell-mediated 
immune response (Wege et al., 1993; 
Collisson et al., 2002; Liu et al., 2001). 
 
Here, we report a novel finding that the N 
protein of the SARS CoV is able to 
“spread” across cells. Several proteins such 
as the HIV TAT (Vives et al., 1997; 
Frankel and Pabo, 1998), Drosophila 
Antennapedia (Joliot et al., 1991), and 
herpes simplex virus structural protein 
VP22 (Elliott and O’Hare, 1997), have 
been described to be able to spread and 
also mediate the delivery of proteins fused 
to it across cell membranes. This process, 
termed “protein transduction”, was thought 
to be energy-independent and receptor-
independent. Recent studies, however, 
indicate that the translocation of proteins 
containing basic peptides or PTD’s across 
cell membranes, was a fixation artefact 
(Lundberg and Johansson, 2002; Richard 
et al., 2003). The mechanism of protein 
transduction is suggested to be mediated 
by non-specific adhesion of PTD’s, 
followed by endocytosis (Console et al., 
2003; Lundberg et al., 2002; Potocky et al., 
2003). 
 
We showed that SARS N protein can be 
exported out of the cells and apparently 
cross cell membranes to neighboring cells. 
We showed that the nucleolar localization 
and spreading of N are artefacts of 
fixation, reminiscent of other PTD-
containing proteins. The mechanism of 
export of N is still unknown, and will be an 
interesting subject for investigation. The 
possible export of N into the interstitial 
fluid could contribute to the 
immunogenicity of N, and makes N a 
potential and unique vaccine candidate for 
T cell immunity. 
 
MATERIALS AND METHODS 
 
Construction of Plasmids 
The N orf was amplified from SARS CoV 
RNA by RT-PCR. RT was performed with 
an oligo-dT primer, and PCR was done 
with specific primers to amplify the N orf. 
To express untagged and tagged proteins in 
mammalian cells, DNA fragments were 
cloned into pXJ40 (Xiao et al., 1991) or 
pXJ40myc respectively. pXJ40GFP (Zhao 
et al., 2000) and pEGFP-N1 (Clontech) 
were used for expressing GFP-fusion 
proteins. For selecting stably transfected 
cell lines, myc-N was cloned into pXJ41, a 
derivative of pXJ40 that contains a 
neomycin-resistance gene. 
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Tissue culture 
Vero E6, green monkey kidney fibroblasts, 
was maintained in standard Dubelcco’s 
Minimal Eagle’s medium supplemented 
with 10% fetal calf serum (HyClone 
Laboratories) and antibiotics, penicillin at 
10 units/ml and streptomycin at 100 µg/ml 
(Sigma, U. S. A.). 
 
To select for stable cell lines expressing 
myc-N, Vero E6 was transfected with 
pXJ41-myc-N overnight without selection. 
The next day, the transfected cells were 
trypsinized and plated at 1/10th, 1/50th and 
1/100th density in medium containing 1 
mg/ml G418 (GIBCO). After 7-10 days, 
isolated colonies were picked and 
transferred to individual wells in 96-well 
plates. G418-resistant clones were 
expanded further. Expression of myc-N 
was shown by Western blot (WB) and 
immunofluorescence (IF) analyses. A cell 
line that expresses a high level of myc-N in 
all the cells, myc-N#13, was selected for 
immunoprecipitating N from the medium 
(Figure 3A). 
 
SARS CoV and IBV cultures in Vero E6 
cells 
Vero E6 were plated at near confluency 
and SARS CoV (strain 2774, Ruan et al., 
2003) added at multiplicity of infection 
(MOI) of 0.1. When the cell monolayer 
showed the desired cytopathic effects 
(CPE), the cells were fixed for 
immunofluorescence (IF) or harvested to 
extract proteins. 
 
IBV (strain P65c1) were used to infect 
Vero-3 cells (Shen et al., 2003) at MOI of 
1. The supernatant was harvested when 
more than 80% of cells showed CPE. Cell 
debris was removed by centrifugation at 
5,000 rpm (Beckman SS34) for 15 min. 
The supernatant containing viral particles 
were extracted for proteins for WB. 
Phosphatase treatment 
Transfected cells were lysed in lysis buffer 
(0.5% TX100, 0.5% NP40, 0.4 mM PMSF, 
1 mM EDTA, 1 mM EGTA), and 
centrifuged to remove cell debris. Twenty 
µg of total protein from the supernatant 
was treated with 10 U active calf intestinal 
phosphatase (CIP, from Roche), at 30oC 
for 30 min. As controls, 20 µg proteins 
were boiled in sample buffer directly, or 
treated with inactivated CIP, in the 
presence of 15 mM p-nitro-
phenylphosphate, to inhibit cellular 
phosphatases. CIP was inactivated by 
incubating the enzyme at 80oC for 10 min. 
After CIP treatment, the samples were 
boiled in sample buffer and any change in 
molecular weight due to dephosphorylation 
of proteins were visualized by WB 
analysis. 
 
Immunoprecipitation (IP) 
Transiently transfected cells did not 
express sufficient protein to be 
immunoprecipitated from the medium. To 
increase the expression, a stably 
transfected Vero E6 cell line in which 
100% of the cells express myc-N, myc-
N#13, was used. The cells were plated in a 
6-cm plate at about 70% confluency for 18 
h, after which and the medium and cells 
were collected. The medium was spun 
twice at 5000 rpm to remove cell debris, 
and 500 µl used for each IP. The cells were 
lysed in lysis buffer (PBS containing 0.5% 
TX100, 0.5% NP40, 1 mM EDTA, 1 mM 
EGTA, 0.4 mM PMSF), and the extracted 
proteins diluted to 1 µg/µl. For each IP, 
100 µg of cellular proteins was used. 
 
Protein A-G beads (Oncogene Research 
Products) were washed twice in IP buffer 
before use. For each IP, 10 µg packed 
volume of beads per 100 µl lysate or 
medium was used, with rabbit anti-N at 
1:5000 dilution. The mixture was 
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incubated overnight at 4oC with constant 
rolling. The beads were washed 5 times in 
cold lysis buffer, and the bound proteins 
eluted in sample buffer by boiling for 3 
min. For confirmation of results, anti-myc-
conjugated agarose (Santa Cruz 
Biochemicals) was also used for IP. The 
presence of bound N protein was detected 
by WB analyses. 
 
IF and WB analyses 
Subconfluent Vero E6 cells were infected 
with SARS CoV at MOI 0.1 and grown on 
coverslips until cells showed a CPE of 
about 25%. The medium was discarded 
and the coverslips fixed in acetone for 20-
30 min on ice. The acetone was then 
removed and the coverslips completely air-
dried. 
 
To observe spreading of N, cells were 
fixed and prepared for IF when they were 
confluent or subconfluent. Fixation for IF 
was done in 100% methanol at –20oC (Goh 
et al., 2001). Anti-myc antibodies (Santa 
Cruz Biochemicals), and fluorescein-
conjugated secondary antibodies (Santa 
Cruz Biochemicals, U.S.A.) were applied 
at 1:100. An anti-N rabbit antiserum 
generated against a GST-N∆N120 (a.a. 
121-422) was used at 1:2000 and mouse 
antisera raised against the same fusion 
protein were used at 1:200 for IF. 
WB analyses were performed as described 
in (Khu et al., 2001). WBs were probed 
with anti-myc (Santa Cruz Biochemicals) 
at 1:1000-1:2000 dilution, anti-N∆N120 
rabbit antiserum at 1:50 000 dilution and 
mouse anti-N∆N120 antisera used at 
1:1000-1:2000 dilution. 
 
RESULTS AND DISCUSSION 
 
N is a phosphorylated protein 
The N protein was expressed as a GST-
fusion protein in bacteria and was found to 
be soluble, but upon elution from GSH-
beads, a large portion of GST-N 
precipitated out. GST-N∆N120 (a.a. 121-
422) was more soluble when eluted from 
GSH beads. Purified GST-N∆N120 (Tan et 
al., 2003) was injected into 2 rabbits and 5 
mice to raise antibodies. All animals 
showed strong immune response to the 
antigen. Figure 1A depicts a WB with one 
mouse antiserum that shows no cross-
reactivity to Vero E6 cell lysate, or to IBV 
viral particles harvested from infected 
culture medium (Figure 1A). A band of 
about 48 kD corresponding to the predicted 
size of unmodified N is seen in virus-
infected cells early in infection (Figure 1A, 
25% CPE). The molecular weight of N is 
higher in late infection (50-75% CPE), 
when expressed alone in Vero E6, and in 
the supernatant containing mature viral 
particles (Figure 1A). This upshift is 
probably due to phosphorylation, as was 
previously reported for other coronavirus 
N proteins (Stohlman et al., 1983; Yoo et 
al., 1992; Wootton et al., 2002). To 
confirm that the increase in molecular 
weight was due to phosphorylation, and to 
define the subdomain of N that is 
phosphorylated, Vero E6 cells were 
transfected with constructs expressing 
myc-tagged deletion mutants, N1, N2 and 
N3 (Figure 3B) and the cell lysates were 
untreated, or treated with inactivated or 
active CIP. Changes in the protein 
molecular sizes due to dephosphorylation 
were analyzed on WBs (Figure 1B). N1 
and N3 showed no obvious change upon 
CIP treatment, indicating that these protein 
regions do not contain many 
phosphorylated amino acid residues. 
Interestingly, N2, when dephosphorylated 
showed a drastic decrease in size to that of 
the predicted unmodified protein. The 
amino acid sequence of this region 
contains 18 serine residues compared to 8 
or 10 in N1 and N3 respectively. Most of 
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the possible phosphorylated sites in N are 
likely to be found in N2. Like their 
coronaviral N relatives, the SARS CoV N 
is also likely to be a phosphoprotein. 
 
 
 
Figure 1: N expression and localization in Vero E6 infected with the SARS virus, 
and in transfected cells. A) 20 µg of protein from uninfected Vero E6 (Vero E6), 
Vero E6 infected with SARS CoV at about 25% CPE and 50-75% CPE, 20 µl 
medium from CPE 50-75% SARS viral culture (SARS sup), 20 µl medium from 
an IBV culture (IBV sup), 20 µg protein from Vero E6 transfected with pXJ40-N 
plasmid were boiled in sample buffer and separated on a 10% gel, and a WB of 
this gel probed with a mouse anti-N serum. B) Myc-tagged N1, N2 and N3 were 
expressed in Vero E6 cells and 20 µg each of untreated extracted protein 
(untreated), protein treated with inactivated CIP (X CIP) or active CIP (CIP) and 
their molecular sizes analyzed by WB analysis probed with mouse anti-N 
antibodies. C) Vero E6 cells infected with SARS CoV at 25% CPE were fixed in 
acetone and stained with mouse anti-N antibodies, followed by anti-mouse-FITC 
secondary antibodies. (a) The localization of N was visualized on a Zeiss 
Axioplan microscope and the image captured on an Axiocam digital camera. The 
DAPI stain shows areas unoccupied by nuclear DNA corresponding to nucleoli 
(No). More detailed IF was visualized on a Biorad Radiance 2000 Confocal 
microscope, showing exclusively nucleolar staining in some cells, while in others, 
both nucleolar and cytoplasmic staining (b). No background signal was seen in 
uninfected cells probed with mouse anti-N antibodies (c). All cells shown here 
were confluent or near confluent. 
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Another point to note is the presence of 
cleaved forms of N protein in virus-
infected cells. Smaller fragments below 25 
kD were detected with anti-N antibodies, 
indicating that these are proteolytic 
fragments of N (Figure 1A). N proteins of 
other coronaviruses have been shown to be 
cleaved by caspases (Eleouet et al., 1997), 
although no caspase cleavage motif is 
present in the SARS CoV N protein 
sequence (Krokhin et al., 2003). More 
detailed biochemical analysis is needed to 
characterize the phosphorylation and 
cleavage of N, and to understand the 
physiological importance of these protein 
modifications. 
 
“Spreading” and nucleolar localization of 
SARS CoV N are artefacts of fixation 
The localization of N was observed in 
SARS-CoV-infected Vero E6 cells by IF 
with mouse anti-N serum. Consistent with 
the localization of N of other 
coronaviruses, SARS-CoV N was also 
found in the cytoplasm and the nucleolus 
(Figure 1C) (Hiscox et al., 2001, Rowland 
et al., 2003). The nucleolar structures 
correspond to the areas unoccupied by 
nuclear DNA (Figure 1C, a). In many cells, 
only nucleolar localization was observed 
(Figure 1C, a), while in other cells, 
cytoplasmic staining was also seen (Figure 
1C, b). N transiently expressed in Vero E6 
cells was also localized to the cytoplasm 
and the nucleolus. The nucleolar 
localization of N is not due to the cross-
reaction of anti-N antibodies to a nucleolar 
protein because uninfected cells 
(Figure1C, c) stained with rabbit or mouse 
anti-N antisera did not show any signal in 
the nucleolus. 
 
In a time course experiment, Vero E6 were 
transfected with a construct expressing 
untagged N (Figure 2A). Six hours after 
transfection, a gradient of N-specific 
staining spreading from the transfected 
cells to surrounding cells was evident. This 
halo of N protein increases with increasing 
time of N expression, so that at 14 hours 
post-transfection, almost all cells in the 
monolayer culture have N in the nucleolus 
and cytoplasm. As a comparison, the N 
protein from IBV was transiently 
expressed in Vero E6 cells does not exhibit 
this spreading phenomenon. 
 
A similar phenomenon described for 
proteins containing PTD’s was recently 
shown to be an artefact of incomplete 
fixation, resulting in the dispersion of PTD 
proteins from endocytic vesicles to the 
cytoplasm, nucleus and other cellular 
structures (Lundberg and Johansson, 2002; 
Richard et al., 2003). To determine if N 
behaves like a PTD protein, a variety of 
fixation conditions were applied on Vero 
E6 cells transiently expressing myc-N. 
Generally, the nucleolar localization of N 
was observed in mild fixation conditions in 
methanol (2.5-7.5 min) at –20oC and 
paraformaldehyde (5-10 min) at 4oC. In 
more stringent fixation conditions N was 
only detected in the cytoplasm. Similarly, 
the spreading effect was not seen in cells 
fixed in methanol for more than 20 min, 
and in cells fixed in PFA even for very 
brief periods (2-5 min). A range of fixation 
conditions and localization data are shown 
in Table 1. This artefactual localization of 
N was confirmed by the observation of live 
Vero E6 cells expressing GFP-N (Figure 
2B) or N-GFP (data not shown). GFP 
fusion proteins were only present in the 
cytoplasm and surrounding cells did not 
show any fluorescence. Upon methanol 
fixation, GFP-N (Figure 2C), GFP-N 
became localized to the nucleolus and 
cytoplasm of the transfected and 
surrounding cells, suggesting that the GFP 
moiety at either the C- or N-terminus did 
not impede the movement of N to the 
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nucleolus and into the surrounding cells 
upon fixation. Together, these data indicate 
that the SARS N behaves like a PTD-
containing protein and that the nucleolar 
localization and spreading of N are 
artefacts of fixation. 
 
 
 
Figure 2: N translocation and nucleolar localization are seen in fixed cells but not 
in live cells. (A) Vero E6 cells were transfected with a construct expressing 
untagged N. Six, 8 and 14 hours post-transfection, and the cells processed for IF 
with anti-N antibodies. Increasing expression and increasing “spreading” of the N 
protein to the cytoplasm and nucleoli of neighboring cells was observed in the 
time-course experiment. These 3 images were taken at the same gain setting on 
the Confocal microscope. B) Vero E6 cells expressing GFP-N were observed 
without fixation. C) Upon fixation, GFP-N expressed in Vero E6 cells appears to 
spread to neighboring cells, and became localized to the nucleolus. Cells in C 
were visualized with a mouse anti-N polyclonal antibody and these images were 
taken on a Radiance 2000 Confocal microscope (Biorad). All cells shown here 
were confluent or near confluent. 
 
A short peptide of basic residues 
(KKDKKKK) towards the C-terminus of 
N is probably not sufficient for membrane 
binding and translocation upon fixation, as 
N3 which contains this basic peptide and 
IBV N which has a similar sequence 
(KKEKKLKK), is not able to spread 
across cells. 
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Table 1: Fixation conditions and N localization 
Fixative, temp Fixation time (min) Staining Nucleolus Spreading 
Methanol, –20oC 2.5  + + + 
 5  + + + 
 7.5 + + + 
 10 + - + 
 15 + - + 
Acetone, -20oC 5 +/- + +   
 20 + + +   
Acetone, 22oC 5 + + +   
 20 + + +   
PFA, 4oC 2.5 - N.D. N.D. 
 5  - N.D. N.D. 
 10 +/- +/- - 
 20 + - - 
PFA, 22oC 2.5 - N.D. N.D. 
 5 +/- +/- - 
 10 + - - 
 20 + - - 
Fixation conditions affect the nucleolar localization and spreading effect of N. 
Vero E6 cells expressing myc-N were fixed with in methanol, acetone or 
paraformaldehyde (PFA) and at various temperatures (temp) for the lengths of 
time indicated. The fixed cells were processed for IF and labeled with mouse 
anti-N antisera followed by anti-mouse IgG conjugated to FITC. The intensity of 
the IF, nucleolar localization and spreading effect observed under each condition 
were recorded. Where the cells were not stained (-), nucleolar localization and 
spreading could not be determined (N.D.). Weak and strong signals are indicated 
as (+/-) and (+) respectively. 
 
Export of N into the medium 
For N to “spread” to surrounding cells, it 
must be exported out of the expressing 
cells into the medium. To detect N in the 
medium, we used a stably transfected Vero 
E6 cell line in which all the cells express 
myc-tagged N. After allowing these cells 
to grow for 18 hours, the medium was 
collected and cellular proteins extracted. 
The cell lysate and medium were incubated 
with anti-N polyclonal antibodies and 
Protein A-G beads. Two bands were 
detected in cell lysates, and both were 
immunoprecipitated by anti-N antibodies 
(Figure 3A, lanes 1, 2). The lower of the 
two bands could correspond to the caspase-
cleaved product or the unphosphorylated 
form, which is not always seen. Although 
myc-N could not be detected in the 
medium (Figure 3A, lane 4), the upper 
band was precipitated by the anti-N 
antibodies from the medium (Figure 3A, 
lane 5). The lower band was not 
immunoprecipitated, indicating that it was 
not exported into the medium. This 
observation also argues against the 
possibility that the presence of N in the 
medium was due to the release of N 
proteins from lysed cells. When no 
antibody was added, no protein was 
immunoprecipitated, indicating that N was 
specifically immunoprecipitated by the 
rabbit anti-N antibody (Figure 3A, lanes 3, 
6). As a confirmation, anti-myc polyclonal 
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with Protein A-G beads, and anti-myc 
monoclonal antibody conjugated to 
agarose beads also immunoprecipitated 
myc-N from the culture medium. 
 
 
 
Figure 3: Requirements for translocation of N to neighboring cells. (A) A stably 
transfected cell line expressing myc-N was plated for 18 h, after which the 
medium was collected and the cells extracted for proteins. Total protein (100 µg 
at 1 µg/µl) and 500 ml medium were incubated with 20 ml packed volume of 
Protein A-G beads with (lanes 2, 5) or without (lanes 3, 6) rabbit anti-N antibody. 
Bound proteins were eluted and detected on a WB with a mouse anti-myc 
antibody. To detect for myc-N expressed in the cells or exported in the medium, 
20 µg of total protein (lane 1) and 30 µl of medium (lane 4) were included on the 
WB. B) A schematic representation of deletion mutants of N, their cellular 
localization and their ability to spread to surrounding cells are summarized. C) 
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Cellular localization of the myc-tagged deletion mutants N1/2, N1, N2, N3 and 
C1/2 was observed in transiently transfected Vero E6 cells. N1, N2 and N3 show 
the same cytoplasmic localization pattern. N1/2 and C1/2 are localized to the 
cytoplasm and nucleolus, but only C1/2 can spread efficiently. 
 
 
N is apparently exported into the medium, 
and this could explain how it can be 
subsequently taken up by cells that do not 
express N. The mechanism of export is not 
yet known, as N does not possess classical 
signal peptide or membrane anchoring 
sequences for targeting it to the ER to the 
exocytosis pathway. N may define a novel 
protein export pathway. The ability of 
SARS N to exit cells could explain how an 
internal viral protein is a major antigen that 
induces strong humoral response in all 
infected patients tested (Tan et al., 2004). 
 
To define if there are sub-domain(s) of N 
that allows N to be exported and therefore 
spread, a series of deletions were made 
(Figure 3B). Fragments N1, N2 and N3, 
which correspond to about one-third of N 
each were localized to the cytoplasm but 
not in the nucleolus, and also failed to 
cross to neighboring cells (Figure 3B, C). 
C1/2 and N1/2, which correspond to the C-
terminal and N-terminal halves of N were 
localized to the nucleolus and cytoplasm, 
but only C1/2 was able to spread well 
(Figure 3C). The minimal region that can 
translocate across cells is the C-terminal 
half of N, and smaller regions contained in 
N2 and N3 were incapable of crossing cell 
membranes. Based on these observations, 
C1/2 of about 27 kD therefore defines the 
minimal region that can be exported out of 
the cells into the medium, and somehow 
cross cell membranes of neighbouring 
cells. 
 
In vitro uptake experiments (Figure 4) in 
which recombinant N was added to the 
cells suggest that cellular modification, 
such as phosphorylation of N may play a 
part in conferring the appropriate 
properties to allow full length N to spread 
across cells, as cells do not take up N 
expressed in bacteria (Figure 4C). 
However, recombinant N microinjected 
into cells can cross cell membranes and 
become localized to neighbouring cells 
upon fixation (Figure 4D). Cellular 
modification, possibly phosphorylation of 
N, allows full-length N to be exported 
and/or adhere to cell membranes. Deletion 
of the N-terminal 120 amino acids also 
allows N to be taken up from the medium 
(Figure 4C). 
 
Interestingly, protein spreading such as 
that exhibited by the RNA-binding ORF3 
protein of plant umbraviruses without the 
formation of mature viral particles, has 
been proposed to be a mechanism for rapid 
viral infection (Taliansky and Robinson, 
2003). It has been suggested that the 
spreading of HSV tegument protein VP22 
serves to prepare cells for subsequent 
infection of HSV virions. 
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Figure 4: Cells “internalize” recombinant N∆N120 but not full-length N. A) 1.5-2 
µg of cleaved and uncleaved recombinant GST-N and GST-N∆N120 were 
separated by gel electrophoresis and stained with Coomassie. B) Vero E6 cells 
were incubated with 5 mM recombinant N and N∆N120 for 15 h, lysed and 15-20 
µg total protein loaded. WB was probed with rabbit anti-N antibody, and then 
reprobed with anti-actin antibody to show equal loading. C) IF of Vero E6 cells 
incubated with recombinant N and N∆N120. Recombinant N was not detected in 
cells while N∆N120 was present in the cytoplasm and nucleolus. D) Vero E6 cells 
were microinjected with recombinant N (5 mg/ml) together with a plasmid 
expressing myc-GST (0.1 mg/ml) using an Eppendorf Microinjector. The cells 
were incubated for 14 hours, then stained for N and myc-tagged GST with anti-N 
and anti-myc antibodies respectively. GST remained in the injected cell, while N 
was detected in neighboring cells. 
 
 
In conclusion, we have shown that the 
SARS CoV N is a phosphoprotein that is 
localized to the cytoplasm, and only to the 
nucleolus under mild fixation conditions. It 
behaves like a PTD protein, in that it is 
able to “spread” to neighbouring cells, and 
is taken up in vitro by cells upon fixation. 
Although the spreading and in vitro uptake 
are artefacts of fixation, the exit of N must 
occur in order for N to spread to 
surrounding cells. This was shown by the 
IP of N from the culture medium. The 
mechanism of export is not known, but is 
dependent on the C-terminal half of N and 
probably cellular modification. 
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